Balsamo (Zambon): "Da 10 anni impegnati nella ricerca per migliorare qualità di vita dei pazienti con Parkinson"

(Adnkronos) - ‘Sostegno alla Campagna della Confederazione in linea con nostro impegno’

Transcript

00:00As a company, Zambon is now 10 years old and focuses its efforts in neurosciences,

00:13especially in terms of research, and in the field of neurosciences, in Parkinson's disease,

00:21with the aim of improving the quality of life of patients.

00:25Parkinson's disease has alarming numbers,

00:31as they show the urgency to give concrete answers to the impact this pathology has on the patient,

00:39on the caregiver and on the society that surrounds the patient.

00:45As a double prevalence in the last 20 years,

00:49the indicator of the global severity of the disease has increased by about 81% in just 20 years.

00:57Therefore, we realize that Parkinson's disease is a strongly debilitating disease,

01:03and therefore it is important to find solutions that, on the one hand,

01:08support the daily life of the patient with the disease,

01:13and therefore, in addition to therapies, in addition to Zambon's commitment to innovation in scientific research,

01:21Zambon also provides support and tools for useful services for patients.

01:28For us, it is important to highlight the impact of a disease as complex as Parkinson's disease,

01:36which unfortunately still accompanies false beliefs that minimize the real difficulties of the disease.

01:44This is in line with the sensitivity of our company,

01:48so the campaign of the Parkinson's Confederation in Italy goes perfectly in this direction,

01:55and from here our commitment to support them on this path begins.